Moreover, to confirm the value of FOXO6 expression on survival (OS and RFS) in patients with gastric cancer, we analyzed the correlation between clinicopathologic parameters and patients outcomes by univariate analysis. This evidence concerns the gene FOXO6 and gastric cancer.